PL2233153T3 - Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową - Google Patents

Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową

Info

Publication number: PL2233153T3
Authority: PL; Poland
Prior art keywords: cross protection; rotavirus vaccine; vaccine inducing; heterotypic cross; heterotypic
Prior art date: 2005-08-17

Application number

PL10159949T

Other languages

English (en)

Inventor

Brigitte Desiree Alberte Colau

Vos Beatrice Arsene Virginie De

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-17

Filing date

2006-08-15

Publication date

2015-06-30

2005-08-17 Priority claimed from GB0516944A external-priority patent/GB0516944D0/en

2005-10-18 Priority claimed from GB0521164A external-priority patent/GB0521164D0/en

2006-05-05 Priority claimed from GB0608962A external-priority patent/GB0608962D0/en

2006-08-15 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2015-06-30 Publication of PL2233153T3 publication Critical patent/PL2233153T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/15—Reoviridae, e.g. calf diarrhea virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
- C12N2720/00011—Details
- C12N2720/12011—Reoviridae
- C12N2720/12311—Rotavirus, e.g. rotavirus A
- C12N2720/12334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Mycology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

PL10159949T 2005-08-17 2006-08-15 Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową PL2233153T3 (pl)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
GB0516944A GB0516944D0 (en)	2005-08-17	2005-08-17	Vaccine
GB0521164A GB0521164D0 (en)	2005-10-18	2005-10-18	Vaccine
GB0608962A GB0608962D0 (en)	2006-05-05	2006-05-05	Vaccine
EP06776899A EP1915173A2 (en)	2005-08-17	2006-08-15	Rotavirus vaccine inducing heterotypic cross protection
EP10159949.6A EP2233153B1 (en)	2005-08-17	2006-08-15	Rotavirus vaccine inducing heterotypic cross protection

Publications (1)

Publication Number	Publication Date
PL2233153T3 true PL2233153T3 (pl)	2015-06-30

Family

ID=37757924

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL10159949T PL2233153T3 (pl)	2005-08-17	2006-08-15	Szczepionka rotawirusowa wywołująca heterotypową ochronę krzyżową

Country Status (25)

Country	Link
US (1)	US20090028828A1 (pl)
EP (2)	EP1915173A2 (pl)
JP (1)	JP5519934B2 (pl)
KR (1)	KR20080036648A (pl)
AR (1)	AR054916A1 (pl)
AU (1)	AU2006281566B2 (pl)
BR (1)	BRPI0615203A2 (pl)
CA (1)	CA2619751C (pl)
CR (1)	CR9759A (pl)
CY (1)	CY1116135T1 (pl)
DK (1)	DK2233153T3 (pl)
EA (1)	EA014328B1 (pl)
ES (1)	ES2534637T3 (pl)
HR (1)	HRP20150310T1 (pl)
IL (1)	IL189289A0 (pl)
MA (1)	MA29700B1 (pl)
MX (1)	MX2008002270A (pl)
NO (1)	NO20080754L (pl)
PE (1)	PE20070235A1 (pl)
PL (1)	PL2233153T3 (pl)
PT (1)	PT2233153E (pl)
SG (1)	SG163571A1 (pl)
SI (1)	SI2233153T1 (pl)
TW (1)	TW200740457A (pl)
WO (1)	WO2007020078A2 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0107510D0 (en)	2001-03-26	2001-05-16	Univ Bristol	New elongase gene and a process for the production of -9-polyunsaturated fatty acids
EP2197283B1 (en) *	2007-09-25	2013-07-17	Aridis Pharmaceuticals	Formulations for preservation of rota virus
US9311112B2 (en) *	2009-03-16	2016-04-12	Apple Inc.	Event recognition
CN103747800A (zh) *	2011-04-28	2014-04-23	国际医学基金会	液体疫苗制剂
CN110227152A (zh) *	2012-04-23	2019-09-13	巴拉特生物技术国际有限公司	轮状病毒疫苗组合物及其制备方法
EP3359651A1 (en)	2015-10-05	2018-08-15	THE UNITED STATES OF AMERICA, represented by the S	Human rota virus g9p[6]strain and use as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992008786A1 (en) *	1990-11-16	1992-05-29	James N. Gamble Institute Of Medical Research	Human rotaviruses, vaccines and methods
SK287261B6 (sk) *	1999-08-17	2010-04-07	Smithkline Beecham Biologicals S.A.	Oslabená ľudská rotavírusová populácia, spôsob jej výroby, vakcínový prostriedok s jej obsahom a jej použitie
MXPA06002459A (es) *	2003-09-02	2006-06-20	Glaxosmithkline Biolog Sa	Vacuna.

2006
- 2006-08-15 JP JP2008526443A patent/JP5519934B2/ja not_active Expired - Lifetime
- 2006-08-15 TW TW095129956A patent/TW200740457A/zh unknown
- 2006-08-15 WO PCT/EP2006/008094 patent/WO2007020078A2/en not_active Ceased
- 2006-08-15 AR ARP060103557A patent/AR054916A1/es not_active Application Discontinuation
- 2006-08-15 SG SG201004843-7A patent/SG163571A1/en unknown
- 2006-08-15 PE PE2006000993A patent/PE20070235A1/es not_active Application Discontinuation
- 2006-08-15 PL PL10159949T patent/PL2233153T3/pl unknown
- 2006-08-15 EP EP06776899A patent/EP1915173A2/en not_active Ceased
- 2006-08-15 CA CA2619751A patent/CA2619751C/en not_active Expired - Lifetime
- 2006-08-15 MX MX2008002270A patent/MX2008002270A/es unknown
- 2006-08-15 ES ES10159949.6T patent/ES2534637T3/es not_active Expired - Lifetime
- 2006-08-15 KR KR1020087006496A patent/KR20080036648A/ko not_active Ceased
- 2006-08-15 DK DK10159949T patent/DK2233153T3/da active
- 2006-08-15 EP EP10159949.6A patent/EP2233153B1/en not_active Expired - Lifetime
- 2006-08-15 US US12/063,602 patent/US20090028828A1/en not_active Abandoned
- 2006-08-15 BR BRPI0615203-1A patent/BRPI0615203A2/pt not_active Application Discontinuation
- 2006-08-15 PT PT101599496T patent/PT2233153E/pt unknown
- 2006-08-15 SI SI200631912T patent/SI2233153T1/sl unknown
- 2006-08-15 EA EA200800320A patent/EA014328B1/ru not_active IP Right Cessation
- 2006-08-15 AU AU2006281566A patent/AU2006281566B2/en not_active Ceased
2008
- 2008-02-05 IL IL189289A patent/IL189289A0/en unknown
- 2008-02-12 NO NO20080754A patent/NO20080754L/no not_active Application Discontinuation
- 2008-02-13 MA MA30653A patent/MA29700B1/fr unknown
- 2008-02-22 CR CR9759A patent/CR9759A/es not_active Application Discontinuation
2015
- 2015-03-18 HR HRP20150310TT patent/HRP20150310T1/hr unknown
- 2015-03-23 CY CY20151100289T patent/CY1116135T1/el unknown

Also Published As

Publication number	Publication date
EA200800320A1 (ru)	2008-10-30
JP5519934B2 (ja)	2014-06-11
EA014328B1 (ru)	2010-10-29
SI2233153T1 (sl)	2015-05-29
NO20080754L (no)	2008-05-15
DK2233153T3 (da)	2015-04-27
TW200740457A (en)	2007-11-01
JP2009504701A (ja)	2009-02-05
WO2007020078A2 (en)	2007-02-22
AU2006281566B2 (en)	2011-09-01
PE20070235A1 (es)	2007-04-04
MX2008002270A (es)	2008-03-27
ES2534637T3 (es)	2015-04-27
KR20080036648A (ko)	2008-04-28
US20090028828A1 (en)	2009-01-29
IL189289A0 (en)	2008-06-05
SG163571A1 (en)	2010-08-30
BRPI0615203A2 (pt)	2011-05-10
MA29700B1 (fr)	2008-08-01
EP2233153B1 (en)	2015-01-21
CA2619751A1 (en)	2007-02-22
CR9759A (es)	2008-05-05
CY1116135T1 (el)	2017-02-08
PT2233153E (pt)	2015-04-20
WO2007020078A3 (en)	2007-05-24
AR054916A1 (es)	2007-07-25
HRP20150310T1 (hr)	2015-06-19
EP1915173A2 (en)	2008-04-30
AU2006281566A1 (en)	2007-02-22
CA2619751C (en)	2016-07-05
EP2233153A1 (en)	2010-09-29

Publication	Publication Date	Title
IL192084A0 (en)	2008-12-29	Vaccine
GB0504436D0 (en)	2005-04-06	Vaccine
ZA200804918B (en)	2011-10-26	Therapeutic vaccine
IL186600A0 (en)	2008-01-20	Novel vaccine formulations
ZA200709518B (en)	2014-01-29	Vaccine composition
IL187769A0 (en)	2008-08-07	Anti-malaria vaccine
IL189289A0 (en)	2008-06-05	Rotavirus vaccine inducing heterotypic cross protection
ZA200801405B (en)	2009-04-29	Rotavirus vaccine inducing heterotypic cross protection
GB0524409D0 (en)	2006-01-11	Vaccines
GB0718650D0 (en)	2007-10-31	Protection sleeve
ZA200709207B (en)	2009-08-26	Vaccine
GB0810662D0 (en)	2008-07-16	Vaccine
GB0515135D0 (en)	2005-08-31	Vaccine
GB0524408D0 (en)	2006-01-11	Vaccines
ZA200709210B (en)	2009-04-29	Vaccine
HK1118223A (en)	2009-02-06	Rotavirus vaccine inducing heterotypic cross protection
GB0511203D0 (en)	2005-07-06	Vaccines
GB0526412D0 (en)	2006-02-08	Vaccine
GB0513194D0 (en)	2005-08-03	Vaccine
GB0513189D0 (en)	2005-08-03	Vaccine
GB0523445D0 (en)	2005-12-28	Vaccine
GB0513191D0 (en)	2005-08-03	Vaccine
GB0515242D0 (en)	2005-08-31	Vaccine
GB0503000D0 (en)	2005-03-16	Anti-atheroma vaccine
GB0521164D0 (en)	2005-11-23	Vaccine